Alta Partners

Alta Partners is a venture capital firm focused on healthcare and life sciences, helping entrepreneurs build companies in the sector since 1996. Its portfolio includes Allakos, a clinical-stage biotechnology company developing antibody therapies for allergic, inflammatory and proliferative diseases, and Dispatch Health, a home-based care delivery business founded in 2013. Other portfolio companies referenced include Kelonia Therapeutics, which develops in vivo CAR-T cell therapies and was recently acquired by Lilly, eGenesis, involved in pig kidney xenotransplant trials, Tyra Biosciences, a clinical-stage precision medicine company, Variant Bio, and Vir Biotechnology, which is running a Phase 2 hepatitis B trial. The firm frames its approach around the view that the healthcare sector has reached a turning point, with technology increasingly connecting physicians, payers and patients to improve outcomes, and it describes itself as dedicated to helping entrepreneurs build companies that challenge the status quo of the sector.